CoChat

Cardiac β1-Adrenoceptor Autoantibodies in Human Heart Disease: Rationale and Design of the E tiology, Ti tre- C ourse, and S urvival (ETiCS) Study

Deubner, Nikolas, Berliner, Dominik, Schlipp, Angela, Gelbrich, Götz, Caforio, Alida L.P., Felix, Stephan B., Fu, Michael, Katus, Hugo, Angermann, Christiane E., Lohse, Martin J., Ertl, Georg, Störk, Stefan, Jahns, Roland · 2010 · European Journal of Heart Failure
Cited by 69

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Aims: Evidence for a pathophysiologic relevance of autoimmunity in human heart disease has substantially increased over the past years. Conformational autoantibodies stimulating the cardiac β1-adrenoceptor (β1-aabs) are considered of importance in heart failure development and clinical pilot studies have shown their prognostic significance in human ‘idiopathic’ cardiomyopathy. Methods: We recently developed a novel highly sensitive fluorescence-based functional assay to detect stimulating β1-aabs. We will use this method to assess Etiology, Titre-Course, and effect on Survival (ETiCS) of β1-aabs in a prospective multicentre study with serial follow-up of patients after a first acute myocarditis or myocardial infarction. Several European core laboratories will jointly study the hypothesis that both disorders may trigger autoimmune reactions leading to the generation of β1-aabs and/or other heart-directed aabs. Further, sera from healthy controls and well-characterized patient cohorts with dilated, ischaemic, or hypertensive cardiomyopathy will be analysed retrospectively for β1-aab prevalence, incidence, persistence, and/or clearance. Conclusion: ETiCS is so far the largest clinical diagnostic study projected to address cardiac autoimmunity. It attempts to unravel the pathophysiology of cardiac autoantibody formation and persistence/clearance. ETiCS will enhance current knowledge on autoimmunity in human heart disease and promote endeavours to develop novel therapies targeting cardiac aabs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfq072

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 69

Metadata

Authors
Deubner, N., Berliner, D., Schlipp, A., Gelbrich, G., Caforio, A. L. P., Felix, S. B., Fu, M., Katus, H., Angermann, C. E., Lohse, M. J., Ertl, G., Störk, S., & Jahns, R.
Venue
European Journal of Heart Failure
Published
2010-07-01
Volume
12
Issue
7
Pages
753-762
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W1950881078
Cited by
69
References
7
FWCI
6.13
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiac β1-Adrenoceptor Autoantibodies in Human Heart Disease: Rationale and Design of the E tiology, Ti tre- C ourse, and S urvival (ETiCS) Study. https://app.cochat.ai/papers/10.1093/eurjhf/hfq072
The paper
Deubner, N., Berliner, D., Schlipp, A., Gelbrich, G., Caforio, A. L. P., Felix, S. B., Fu, M., Katus, H., Angermann, C. E., Lohse, M. J., Ertl, G., Störk, S., & Jahns, R. (2010). Cardiac β1-Adrenoceptor Autoantibodies in Human Heart Disease: Rationale and Design of the E tiology, Ti tre- C ourse, and S urvival (ETiCS) Study. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfq072

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.